Area of research
Pharmaceutical Science · Pulmonary and Respiratory Medicine
Research interest
Research interests include Chemistry, Medicine, Drug delivery, Nasal administration, Materials science, and Drug.
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Dry Powder Inhalation Technology for Heart Targeting Applied to Calcium Phosphate Nanoparticles Loaded with Active Substances
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
<i>In vivo</i> nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy
Opportunity and challenges of nasal powders: Drug formulation and delivery
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles
“Pierce and inhale” design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs
High shear mixing of lactose and salmeterol xinafoate dry powder blends: Biopharmaceutic and aerodynamic performances
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake
Pure insulin highly respirable powders for inhalation
Agglomerated Oral Dosage Forms of Artemisinin/β-Cyclodextrin Spray-Dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability
Investigation of the swelling behavior of Dome Matrix drug delivery modules by high-resolution X-ray computed tomography